Повишени нива на АСАТ и/ или АЛАТ са асоциирани със ситаксентан натрий.
In phase 2 and 3 oral studies in patients with PAH, elevations in ALT and/ or AST > 3 ULN were observed in 5% of placebo-treated patients (N = 155) and 7% of Thelin 100 mg-treated patients (N = 887).